| Literature DB >> 33441355 |
Mark Tarrant1, Mary Carter2, Sarah Gerard Dean2, Rod Taylor3, Fiona C Warren2, Anne Spencer2, Jane Adamson2, Paolo Landa4, Chris Code5, Amy Backhouse2, Ruth A Lamont2, Raff Calitri2.
Abstract
OBJECTIVES: Pilot feasibility randomised controlled trial (RCT) for the singing groups for people with aphasia (SPA) intervention to assess: (1) the acceptability and feasibility of participant recruitment, randomisation and allocation concealment; (2) retention rates; (3) variance of continuous outcome measures; (4) outcome measure completion and participant burden; (5) fidelity of intervention delivery; (6) SPA intervention costs; (7) acceptability and feasibility of trial and intervention to participants and others involved.Entities:
Keywords: social medicine; stroke; stroke medicine
Year: 2021 PMID: 33441355 PMCID: PMC7812101 DOI: 10.1136/bmjopen-2020-040544
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Consolidated Standards of Reporting Trials diagram of participant recruitment and retention. SPA, singing groups for people with aphasia.
Baseline demographic characteristics of participants
| SPA (n=20) | Control (n=21) | |
| Gender; n (%) | ||
| Male | 12 (60) | 13 (62) |
| Female | 8 (40) | 8 (38) |
| Age (years); mean (SD); median (min, max) | 65.2 (12.2); 64 (43, 82) | 67.7 (8.3); 67 (54, 87) |
| IMD quintile; n (%) | ||
| Quintile 1 (most deprived) | 2 (10) | 0 (0) |
| Quintile 2 | 5 (25) | 5 (24) |
| Quintile 3 | 5 (25) | 7 (33) |
| Quintile 4 | 6 (30) | 6 (29) |
| Quintile 5 (least deprived) | 2 (10) | 3 (14) |
| Ethnic group; n (%) | ||
| White | 20 (100) | 19 (90) |
| Black | 0 (0) | 1 (5) |
| Asian | 0 (0) | 1 (5) |
| Aphasia type: n (%) | ||
| Fluent | 15 (75) | 16 (76) |
| Non-fluent | 5 (25) | 5 (24) |
| Aphasia severity; n (%) | ||
| Mild | 14 (70) | 13 (62) |
| Moderate | 3 (15) | 4 (19) |
| Severe | 3 (15) | 4 (19) |
| Site; n (%) | ||
| Group A | 7 (35) | 7 (33) |
| Group B | 7 (35) | 7 (33) |
| Group C | 6 (30) | 7 (33) |
| Time since stroke (years); mean (SD); median (min, max) | 4.6 (3.8); 3.9 (0.5, 14.7) | 5.6 (6.7); 2.3 (0.3, 21.0)* |
| Time since stroke; n (%) | ||
| Less than 1 year | 2 (10) | 5 (24) |
| 1–2 years | 4 (20) | 3 (14) |
| 2–5 years | 6 (30) | 5 (24) |
| 5–10 years | 6 (30) | 3 (14) |
| More than 10 years | 2 (10) | 5 (24) |
| Other medical problems; n (%) | 16 (80) | 13 (62) |
| Medications; n (%) | 20 (100) | 20 (95) |
| Employed | 2 (10) | 2 (10) |
| Retired | 15 (75) | 19 (90) |
| Participation in group activity | 16 (80) | 18 (86) |
| Simplified Modified Rankin Scale; n (%) | ||
| 0 | 3 (15) | 1 (5) |
| 1 | 2 (10) | 0 (0) |
| 2 | 9 (45) | 5 (24) |
| 3 | 6 (30) | 15 (71) |
| SLT received | ||
| Yes | 17 (85) | 14 (67) |
| Amount of SLT received (hours); mean (SD), median (min, max) | 22.1 (28.4); 7 (0, 104) | 36.0 (74.5); 10 (0, 312) |
*Based on 20 participants; one extreme outlier excluded. With inclusion of this outlier, mean=8.3 years (SD=4.3).
SLT, speech and language therapist; SPA, singing groups for people with aphasia.
Outcome measures at baseline and follow-up assessment points
| Outcome* | Baseline | 3-month follow-up | 6-month follow-up | ||||
| SPA (n=20) | Control (n=21) | SPA (n=17) | Control (n=19) | SPA (n=18) | Control (n=16) | SPA−control (95% CI)† | |
| ICECAP-A | 0.830 (0.124), 17; (0.534, 0.969) | 0.755 (0.157), 20; (0.269, 0.946) | 0.819 (0.096), 16; (0.663, 0.968) | 0.748 (0.181), 19; (0.249, 0.946) | 0.813 (0.100), 18; (0.599, 947) | 0.777 (0.162), 16; (0.513, 973) | −0.011 (−0.098 to 0.076) |
| SAQOL overall | 3.6 (0.8), 20; (2.4, 4.9) | 3.5 (0.6), 21; (2.7, 4.9) | 3.6 (0.8), 17; (2.5, 4.9) | 3.6 (0.7), 19; (2.0, 4.6) | 3.7 (0.8), 18; (2.4, 4.7) | 3.4 (0.7), 15; (2.2, 4.6) | 0.2 (−0.2 to 0.7) |
| SAQOL physical | 3.7 (0.9), 19; (2.0, 5.0) | 3.8 (0.8), 18; (2.7, 4.9) | 4.0 (0.8), 17; (2.6, 5.0) | 3.7 (0.9), 17; (2.1, 4.9) | 3.9 (0.8), 18; (2.6, 5.0) | 3.6 (1.0), 15; (2.1, 4.9) | 0.2 (−0.1 to 0.6) |
| SAQOL communication | 3.2 (1.2), 18; (1.1, 5.0) | 3.3 (0.8), 21; (2.0, 4.9) | 3.3 (1.1), 17; (1.6, 4.7) | 3.6 (0.9), 18; (2.1, 5.0) | 3.5 (1.0), 17; (1.7, 4.7) | 3.5 (0.7), 15; (2.6, 5.0) | 0.2 (−0.2 to 0.7) |
| SAQOL psychosocial | 3.3 (1.1), 20; (1.4, 5.0) | 3.3 (0.8), 21; (1.8, 4.9) | 3.4 (0.9), 17; (2.3, 4.9) | 3.5 (0.9), 19; (1.9, 4.7) | 3.6 (1.0), 18; (1.6, 4.8) | 3.2 (0.9), 16; (1.9, 4.6) | 0.3 (−0.3 to 0.9) |
| EQ-5D-5L | 0.711 (0.242), 19;(0.223, 1.00) | 0.729 (0.164), 20;(0.448, 1.00) | 0.683 (0.265), 17; (−0.019, 1.00) | 0.727 (0.239), 19;(0.250, 1.00) | 0.748 (0.239), 18; (0.043, 1.00) | 0.651 (0.241), 16; (0.218, 1.00) | 0.086 (−0.051 to 0.223) |
| EQ-5D health state (0–100) | 67 (22), 19; (25, 100) | 64 (21), 21; (15, 96) | 70 (17), 17; (50, 100) | 59 (23), 19; (18, 90) | 74 (15), 18; (50, 100) | 66 (25), 16; (30, 100) | 4 (−9 to 17) |
| mRNLI total | 20.4 (7.1), 19; (9.9, 33.0) | 20.1 (6.7), 21; (10.0, 33.0) | 23.1 (5.3), 17; (15.0, 33.0) | 22.1 (8.0), 19; (3.0, 33.0) | 23.9 (6.2), 18; (14.0, 33.0) | 22.1 (7.5), 16;(8.0, 32.0) | 1.0 (−3.5 to 5.5) |
| mRNLI daily functioning | 12.8 (5.4), 18; (2.0, 21.0) | 12.2 (4.9), 19; (2.0, 21.0) | 14.3 (4.0), 17; (6.0, 21.0) | 13.7 (5.3), 18; (1.0, 21.0) | 15.1 (4.6), 17; (8.0, 21.0) | 13.4 (5.7), 16;(5.0, 21.0) | 1.9 (−1.7 to 5.4) |
| mRNLI personal integration | 7.9 (3.1), 19; (3.0, 12.0) | 8.0 (2.9), 21; (3.0, 12.0) | 8.8 (2.0), 17; (6.0, 12.0) | 8.1 (2.9), 19; (2.0, 12.0) | 8.9 (2.1), 17; (4.0, 12.0) | 8.7 (2.5), 16; (3.0, 11.0) | 0.7 (−0.8 to 2.2) |
| COAST | 60 (18), 20; (25, 86) | 63 (16), 20; (36, 94) | 69 (16), 18; (38, 94) | 72 (15), 16; (53, 99) | −1 (−7 to 5) | ||
| CarerQoL | 9.2 (2.3), 5; (6.0, 12.0) | 9.6 (2.6), 7; (6, 14) | 9.0 (2.7), 4; (7, 13) | 9.0 (3.1), 5; (5, 13) | Not reported | ||
| CarerQoL level of happiness | 6.8 (0.8), 5; (6.0, 8.0) | 7.4 (1.8), 7; (5.0, 10.0) | 6.0 (3.4), 4; (2, 10) | 7.6 (1.8), 5; (5.0, 10.0) | Not reported | ||
Higher scores indicate better outcomes on outcome measures (ie, greater quality of life, greater reintegration into normal living, more effective communication).
*Outcomes are reported as mean (SD), number of cases; (minimum, maximum).
†Analyses adjusted for baseline score, gender, site, aphasia severity and aphasia type.
CarerQoL, carer quality of life; COAST, Communication Outcome after Stroke Scale; EQ-5D-5L, EuroQol Quality of Life Scale; ICECAP-A, ICEpop CAPability measure for Adults; mRNLI, modified Reintegration to Normal Living Index; SAQOL-39, Stroke and Aphasia Quality of Life Scale; SPA, singing groups for people with aphasia.
Sample size estimates for candidate primary outcomes
| Outcome measure | MCID | SD | Sample size required |
| EQ-5D* | 0.1 | 0.2 | 284 |
| SAQOL-39† | 0.1 increments from 0.1 to 0.5 | 0.81 | 144–2760 |
| mRNLI‡ | 14.8 | 6.8 | 12 |
| ICECAP-A§ | 0.07 | 0.07 | 234 |
*MCID from Chen et al 51; SD from Kind et al.52
†MCIDs and SDs from Jones et al. 50
‡MCID from https://www.sralab.org/rehabilitation-measures/reintegration-normal-living-index: based on the full version of the RNLI and not the modified version; SD from our own trial sample.
§MCID from Hackert et al 53; SD from the SPA pilot sample.
EQ-5D, EuroQol Quality of Life Scale; ICECAP-A, ICEpop CAPability measure for Adults; MCID, minimum clinically important difference; mRNLI, modified Reintegration to Normal Living Index; SAQOL-39, Stroke and Aphasia Quality of Life Scale; SPA, singing groups for people with aphasia.
Reports of AEs/ SAEs
| Group | Severity | Total | Related | Probable | Possible | Unrelated | Reporting events (n) |
| SPA | AE | 4 | 2* | 0 | 0 | 2† | 3 |
| SAE | 5 | 0 | 0 | 1‡ | 4§ | 2 | |
| Control | AE | 1 | 0 | 0 | 0 | 1 | 1 |
| SAE | 0 | 0 | 0 | 0 | 0 | 0 |
*Events were: fall off chair at singing group; trap thumb between chairs at singing group (two different participants).
†Events were: falls at home (same participant).
‡Event was: fall.
§1×fall; 1×death (same participant); 1×fall, 1×lung infection (same participant).
AE, adverse event; SAE, serious AE.